Rifaat Safadi earned his MD from Hadassah-Hebrew University of Jerusalem (1989) following a BSc in Health Science (1986) from the same institution. He is now a Full Professor of Medicine, Gastroenterology and Hepatology at Hadassah University Hospital, where he directs both the Liver Institute and Clinical Research Center (since 1998). His work in hepatology has resulted in 200+ publications; leadership roles including Chairman of the Israel Association for the Study of the Liver (2013-2016) and Treasurer of the Israeli Society of Gastroenterology (2020-2023); and international committee memberships with EASL (2007-2010) and AASLD (2010-2012). His clinical and research topics mainly include fatty liver disease, viral hepatitis, cirrhosis complications, liver transplantation, inflammatory bowel diseases, and pioneering investigations into lymphocyte-hepatic fibrogenesis interactions. Professor Safadi's translational research has led to the discovery of patented immunometabolic checkpoints in NK cells and myofibroblasts, driving novel therapeutic developments for liver and bowel diseases.